SCHEMBL7985401

SCHEMBL7985401

CC(C)c1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.64
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ KMT2A Q03164 3/20 0.57
▸ BRD4 O60885 1/20 0.47
▸ PNP P00491 2/20 0.45
▸ PARN O95453 1/20 0.45
▸ CNOT7 Q9UIV1 1/20 0.45
▸ GAA P10253 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ PDE1A P54750 1/20 0.44
▸ PDE1B Q01064 1/20 0.44
▸ PDE1C Q14123 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CXCL8 P10145 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974022 0.83 SMN1; SMN2 (0.62) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7975251 0.81 SMN1; SMN2 (0.60) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL1713573 0.81 PNP (0.64) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7985407 0.80 CNOT7 (0.54) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7975265 0.80 SMN1; SMN2 (0.61) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
Hydrochloric Acid SCHEMBL7773119 0.80 PNP (0.63) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
Hydrochloric Acid SCHEMBL5718893 0.80 PNP (0.63) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7989405 0.79 SMN1; SMN2 (0.57) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7985469 0.79 SMN1; SMN2 (0.57) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7988094 0.79 SMN1; SMN2 (0.60) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback